tirzepatide ncbi The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity Insights into the Mechanism of

The GSTO1 C1-31 complex was formed by incubating GSTO1 (2.66 mg ml 1 ) in a 1:1.5 molar ratio with C1-31 at 4 C for 24 h, then concentrated to 23.9 mg ml 1 before crystallization

Weekly updates

Why Most Laxatives Dont Work Well for GLP-1 Patients Stimulant laxatives senna, bisacodyl force your gut to contract

Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects

Medical team designs personalized treatment plans rather than cookie-cutter protocols

Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM